Xero Limited Stock Performance
| XROLF Stock | USD 108.40 0.00 0.00% |
On a scale of 0 to 100, Xero holds a performance score of 15. The firm maintains a market beta of 0.11, which attests to not very significant fluctuations relative to the market. As returns on the market increase, Xero's returns are expected to increase less than the market. However, during the bear market, the loss of holding Xero is expected to be smaller as well. Please check Xero's potential upside, as well as the relationship between the skewness and day typical price , to make a quick decision on whether Xero's historical returns will revert.
Risk-Adjusted Performance
15 of 100
Weak | Strong |
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Xero Limited are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. Despite nearly unfluctuating essential indicators, Xero reported solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 611.4 M | |
| Total Cashflows From Investing Activities | -430 M |
Xero |
Xero Relative Risk vs. Return Landscape
If you would invest 9,522 in Xero Limited on September 4, 2024 and sell it today you would earn a total of 1,318 from holding Xero Limited or generate 13.84% return on investment over 90 days. Xero Limited is currently producing 0.2119% returns and takes up 1.1032% volatility of returns over 90 trading days. Put another way, 9% of traded pink sheets are less volatile than Xero, and 96% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Xero Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Xero's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Xero Limited, and traders can use it to determine the average amount a Xero's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1921
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | XROLF | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.1 actual daily | 9 91% of assets are more volatile |
Expected Return
| 0.21 actual daily | 4 96% of assets have higher returns |
Risk-Adjusted Return
| 0.19 actual daily | 15 85% of assets perform better |
Based on monthly moving average Xero is performing at about 15% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Xero by adding it to a well-diversified portfolio.
Xero Fundamentals Growth
Xero Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Xero, and Xero fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Xero Pink Sheet performance.
| Return On Equity | -0.0191 | |||
| Return On Asset | 0.0211 | |||
| Profit Margin | (0.02) % | |||
| Operating Margin | 0.07 % | |||
| Current Valuation | 7.76 B | |||
| Shares Outstanding | 151.68 M | |||
| Price To Earning | 250.59 X | |||
| Price To Book | 11.80 X | |||
| Price To Sales | 6.24 X | |||
| Revenue | 1.02 B | |||
| EBITDA | 195.48 M | |||
| Cash And Equivalents | 936.06 M | |||
| Cash Per Share | 6.26 X | |||
| Total Debt | 822.42 M | |||
| Debt To Equity | 0.99 % | |||
| Book Value Per Share | 7.22 X | |||
| Cash Flow From Operations | 236.37 M | |||
| Earnings Per Share | (0.04) X | |||
| Total Asset | 2.18 B | |||
| Retained Earnings | (282 M) | |||
| Current Asset | 169 M | |||
| Current Liabilities | 53 M | |||
About Xero Performance
By analyzing Xero's fundamental ratios, stakeholders can gain valuable insights into Xero's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Xero has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Xero has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Xero Limited, together with its subsidiaries, operates as a software as a service company in New Zealand, Australia, the United Kingdom, and internationally. Xero Limited was incorporated in 2006 and is headquartered in Wellington, New Zealand. Xero is traded on OTC Exchange in the United States.Things to note about Xero Limited performance evaluation
Checking the ongoing alerts about Xero for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Xero Limited help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| The company reported the revenue of 1.02 B. Net Loss for the year was (9.11 M) with profit before overhead, payroll, taxes, and interest of 957.43 M. | |
| About 16.0% of the company outstanding shares are owned by insiders |
- Analyzing Xero's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Xero's stock is overvalued or undervalued compared to its peers.
- Examining Xero's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Xero's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Xero's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Xero's pink sheet. These opinions can provide insight into Xero's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Xero Pink Sheet analysis
When running Xero's price analysis, check to measure Xero's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xero is operating at the current time. Most of Xero's value examination focuses on studying past and present price action to predict the probability of Xero's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xero's price. Additionally, you may evaluate how the addition of Xero to your portfolios can decrease your overall portfolio volatility.
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |